Belle Mead, NJ, United States of America

Xin Zhao

This inventor holds 14 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Amazon Technologies, Inc., Ptc Therapeutics, Inc., F. Hoffmann-La Roche Ag. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Zhao. Retrieved from https://idiyas.com/inventor/xin-zhao-gmsxmney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 8.0

ph-index = 10

Forward Citations = 599(Granted Patents)


Location History:

  • Seattle, WA (US) (2016 - 2021)
  • Belle Mead, NJ (US) (2016 - 2023)
  • Mercer Island, WA (US) (2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Inventor Xin Zhao - Pioneering Innovations in Belle Mead

Introduction: Xin Zhao is a visionary inventor based in Belle Mead, NJ, known for her groundbreaking contributions to various fields.

Latest Patents: Xin Zhao holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced healthcare devices.

Career Highlights: With a background in engineering and a passion for sustainability, Xin Zhao has led numerous projects that have revolutionized the way we approach environmental challenges.

Collaborations: Throughout her career, Xin Zhao has collaborated with leading research institutions, universities, and companies to bring her innovative ideas to life.

Conclusion: Xin Zhao's dedication to innovation and sustainability continues to inspire the next generation of inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…